Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Variations in Sensitivity to Ionizing Radiation in Relation to p53 Mutation Point

KUMIO OKAICHI, MIWA IDE-KANEMATSU, NANAKA IZUMI, NAOKO MORITA, YUTAKA OKUMURA and MAKOTO IHARA
Anticancer Research September 2008, 28 (5A) 2687-2690;
KUMIO OKAICHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Okaichi{at}net.nagasaki-u.ac.jp
MIWA IDE-KANEMATSU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NANAKA IZUMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAOKO MORITA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTAKA OKUMURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAKOTO IHARA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 28 no. 5A 2687-2690
PMID 
19035295

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 20, 2008
  • Revision received June 19, 2008
  • Accepted July 1, 2008
  • Published online September 1, 2008.

Copyright & Usage 
Copyright© 2008 International Institute of Anticaner Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. KUMIO OKAICHI,
  2. MIWA IDE-KANEMATSU,
  3. NANAKA IZUMI,
  4. NAOKO MORITA,
  5. YUTAKA OKUMURA and
  6. MAKOTO IHARA
  1. Department of Radiation Biophysics, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan
  1. Correspondence to: Kumio Okaichi, Ph.D., Department of Radiation Biophysics, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 12-4 Sakamoto 1-chome, Nagasaki 852-8523, Japan. Tel: +81 958197102, Fax: +81 958197104, e-mail: Okaichi{at}net.nagasaki-u.ac.jp

Statistics from Altmetric.com

Cited By...

  • 23 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 28, Issue 5A
September-October 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Variations in Sensitivity to Ionizing Radiation in Relation to p53 Mutation Point
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Variations in Sensitivity to Ionizing Radiation in Relation to p53 Mutation Point
KUMIO OKAICHI, MIWA IDE-KANEMATSU, NANAKA IZUMI, NAOKO MORITA, YUTAKA OKUMURA, MAKOTO IHARA
Anticancer Research Sep 2008, 28 (5A) 2687-2690;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Variations in Sensitivity to Ionizing Radiation in Relation to p53 Mutation Point
KUMIO OKAICHI, MIWA IDE-KANEMATSU, NANAKA IZUMI, NAOKO MORITA, YUTAKA OKUMURA, MAKOTO IHARA
Anticancer Research Sep 2008, 28 (5A) 2687-2690;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Transcriptional Specificity in Various p53-Mutant Cells
  • Phosphorylation of p53 Modifies Sensitivity to Ionizing Radiation
  • Tumor Cure Probability During {alpha}-RIT of Ovarian Cancer with Different Radiation Sensitivity
  • Google Scholar

More in this TOC Section

  • Extracellular cGMP Levels Predict the Response of C4-1 Cervical Cancer Cells to Ionizing Radiation
  • Pan-Cancer Landscape of CDK1 Uncovers Its Potential Prognostic Significance and Therapeutic Targeting in Adrenocortical Carcinoma
  • Lenvatinib Exhibits Potent Anti-tumor Activity and Favorable Safety Profile in a Colorectal Cancer Xenograft Model
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire